Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.18.7713

Impact of Caspase-8 (CASP8) -652 6N Del and D302H Polymorphisms on Prostate Cancer in Different Ethnic Groups  

Zhang, Cheng-Dong (Medical Scientific Research Center, Guangxi Medical University)
Li, Hong-Tao (Medical Scientific Research Center, Guangxi Medical University)
Liu, Kun (Department of Gastroenterology, The Third Hospital of Nanchang City)
Lin, Zhi-Di (Department of Urology, Affiliated Hospital of Youjiang Medical College for Nationalities)
Peng, Qi-Liu (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University)
Qin, Xue (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University)
He, Min (Medical Scientific Research Center, Guangxi Medical University)
Wu, Hua (Medical Scientific Research Center, Guangxi Medical University)
Mo, Zeng-Nan (Department of Urology, First Affiliated Hospital of Guangxi Medical University)
Yang, Xiao-Li (Medical Scientific Research Center, Guangxi Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.18, 2014 , pp. 7713-7718 More about this Journal
Abstract
Background: Despite evidence suggesting roles for caspase-8 (CASP8) -652 6N del and D302H polymorphisms in prostate cancer (PCa), the association of these polymorphisms with PCa risk remains inconclusive. Therefore, a meta-analysis was performed to more precisely estimate the association of CASP8 -652 6N del and D302H polymorphisms with PCa susceptibility. Materials and Methods: A comprehensive literature search was conducted to identify all case-control studies of CASP8 D302H and -652 6N del polymorphisms and PCa risk. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the association and the precision of the estimate, respectively. Results: Nine -625 6N del studies and 4 D302H studies were included. CASP8 -652 6N del and D302H polymorphisms were not significantly associated with PCa risk in the overall analyses. However, in the subgroup analysis stratified by ethnicity, -625 6N del was significantly associated with PCa risk in the East Asian and Indian populations under the recessive model. Furthermore, the subgroup analysis strongly suggested that D302H was associated with lower PCa risk in the Non-Indian population under the dominant model. Conclusions: In our meta-analysis, ethnic-specific differences were evident in the association of CASP8-625 6N del and D302H polymorphisms with PCa risk.
Keywords
Prostate carcinoma; CASP8; SNPs; meta-analysis; ethnic groups;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Kesarwani P, Mandal RK, Maheshwari R, et al (2011). Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer. BJU Int, 107, 471-6.   DOI   ScienceOn
2 Klein LT, Lowe FC (1997). The effects of prostatic manipulation on prostate-specific antigen levels. Urol Clin North Am, 24, 293-7.   DOI   ScienceOn
3 Li YY, Wang XM, Lu XZ (2014). KCNQ1 rs2237892 C-->T gene polymorphism and type 2 diabetes mellitus in the Asian population: a meta-analysis of 15,736 patients. J Cell Mol Med, 18, 274-82.   DOI
4 Lubahn J, Berndt SI, Jin CH, et al (2010). Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. Prostate, 70, 646-53.
5 MacPherson G, Healey CS, Teare MD, et al (2004). Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst, 96, 1866-9.   DOI   ScienceOn
6 Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
7 Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.   DOI   ScienceOn
8 Meyer A, Coinac I, Bogdanova N, et al (2013). Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy. Urol Oncol, 31, 74-81.   DOI   ScienceOn
9 Michailidou K, Hall P, Gonzalez-Neira A, et al (2013). Largescale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet, 45, 353-61.   DOI   ScienceOn
10 Sergentanis TN, Economopoulos KP (2010). Association of two CASP8 polymorphisms with breast cancer risk: a metaanalysis. Breast Cancer Res Treat, 120, 229-34.   DOI
11 Son JW, Kang HK, Chae MH, et al (2006). Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet, 169, 121-7.   DOI   ScienceOn
12 Sun T, Gao Y, Tan W, et al (2007). A six-nucleotide insertiondeletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet, 39, 605-13.   DOI   ScienceOn
13 Turnbull C, Ahmed S, Morrison J, et al (2010). Genomewide association study identifies five new breast cancer susceptibility loci. Nat Genet, 42, 504-7.   DOI   ScienceOn
14 Wu Z, Li Y, Li S, et al (2013). Association between main Caspase gene polymorphisms and the susceptibility and prognosis of colorectal cancer. Med Oncol, 30, 565.   DOI   ScienceOn
15 Zhao CX, Liu M, Wang JY, et al (2013). Association of 8 loci on chromosome 8q24 with prostate carcinoma risk in northern Chinese men. Asian Pac J Cancer Prev, 14, 6733-8.   과학기술학회마을   DOI   ScienceOn
16 Zheng SL, Sun J, Wiklund F, et al (2008). Cumulative association of five genetic variants with prostate cancer. N Engl J Med, 358, 910-9.   DOI   ScienceOn
17 Zhou X, Gu Y, Zhang SL (2012). Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis. Asian Pac J Cancer Prev, 13, 4909-14.   과학기술학회마을   DOI   ScienceOn
18 Cybulski. C, Wokolorczyk. D, Gliniewicz. B (2007). A sixnucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population. Breast Cancer Res Treat, 112, 367-368.
19 Benjamini Y, Hochberg Y (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Royal Statistical Society, 57, 11.
20 Bethke L, Sullivan K, Webb E, et al (2009). CASP8 D302H and meningioma risk: an analysis of five case-control series. Cancer Lett, 273, 312-5.   DOI   ScienceOn
21 DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.   DOI   ScienceOn
22 Frank B, Rigas SH, Bermejo JL, et al (2008). The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res Treat, 111, 139-44.   DOI   ScienceOn
23 Fu G, Tang J, Wang M, et al (2011). CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men. J Biomed Res, 25, 128-34.   DOI   ScienceOn
24 George GP, Mandal RK, Kesarwani P, et al (2010). Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: a case-control study in cohort of North India. Urol Oncol, 30, 781-9.
25 Ho PK, Hawkins CJ (2005). Mammalian initiator apoptotic caspases. FEBS J, 272, 5436-53.   DOI   ScienceOn
26 Haiman CA, Garcia RR, Kolonel LN, et al (2008). A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nat Genet, 40, 259-60.   DOI   ScienceOn
27 Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.   DOI   ScienceOn
28 Hirschhorn JN, Lohmueller K, Byrne E, et al (2002). A comprehensive review of genetic association studies. Genet Med, 4, 45-61.   DOI   ScienceOn
29 Holm S (1979). A simple sequentially rejective multiple test procedure. Scandinavian J Statistics, 6, 65-70.